PTP
VBIV

Platform Technology Partners’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Platform Technology Partners’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-393
Closed -$34K – 249
2020
Q3 		$34K Sell
393
-610
-61% -$71.1K 0.02% 198
2020
Q2 		$93K Buy
1,003
+216
+27% +$11.9K 0.07% 182
2020
Q1 		$22K Sell
787
-1,896
-71% -$73.7K 0.02% 175
2019
Q4 		$111K Buy
+2,683
New +$58.7K 0.08% 170

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Platform Technology Partners's VBIV Position: Q4 2020 in Review

Platform Technology Partners sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 393 shares — an estimated $34K sold.

Platform Technology Partners first reported a position in VBIV in Q4 2019 and held it in 4 quarters. The position peaked at $111K in Q4 2019. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

  • Platform Technology Partners reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
  • Platform Technology Partners sold 393 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020, an estimated $34K.
  • Platform Technology Partners first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 4 quarters.
  • Platform Technology Partners's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $111K in Q4 2019.
  • 122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.